To further confirm that IFN induces the lncRNA GAS5 via the JAK‐STAT signaling pathway, we simultaneously treated esophageal cancer cells with IFN‐β and the JAK inhibitor ruxolitinib. The gene discussed is IFNA1; the disease is esophageal cancer.